Cargando…
MicroRNA-338-3p Suppresses Proliferation of Human Liver Cancer Cells by Targeting SphK2
Recent studies have revealed abnormal expression of miRNAs in various tumors. Although microRNA-338-3p (miR-338-3p) plays an important role in many types of tumors, its influence on liver cancer (LC) is unknown. In this study, we found that expression of miR-338-3p was decreased in LC cells and tiss...
Autores principales: | Xiao, Geqiong, Wang, Qiong, Li, Bo, Wu, Xiaohui, Liao, Hui, Ren, Yili, Ai, Ning |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cognizant Communication Corporation
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7844730/ https://www.ncbi.nlm.nih.gov/pubmed/29321083 http://dx.doi.org/10.3727/096504018X15151495109394 |
Ejemplares similares
-
Mammalian sphingosine kinase (SphK) isoenzymes and isoform expression: challenges for SphK as an oncotarget
por: Hatoum, Diana, et al.
Publicado: (2017) -
Therapeutic Potential of SphK1 Inhibitors Based on Abnormal Expression of SphK1 in Inflammatory Immune Related-Diseases
por: Bu, Yanhong, et al.
Publicado: (2021) -
The therapeutic value of the SphK1-targeting microRNA-3677 in human osteosarcoma cells
por: Yao, Chen, et al.
Publicado: (2020) -
Inhibition of SphK1 reduces radiation-induced migration and enhances sensitivity to cetuximab treatment by affecting the EGFR/SphK1 crosstalk
por: Schiefler, Carlotta, et al.
Publicado: (2014) -
Activation of SphK2 contributes to adipocyte-induced EOC cell proliferation
por: Dai, Lan, et al.
Publicado: (2022)